Cooperative Agreement U44NS114420

The Spinex Inc. was awarded a $4,719,091 Project Grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to develop and clinically validate a transcutaneous electrical spinal cord neuromodulation (TESCON) device to mitigate symptoms of neurogenic bladder resulting from spinal cord injury. The award, made under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support Spinex in building a commercial...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $411,941 to Drexel University to conduct research on identifying novel trunk reflex pathways and how they differ after neonatal versus adult spinal cord injury in animal models. The key objectives are to test the hypothesis that the newly discovered contralateral monosynaptic trunk...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports development of a novel screening technology to identify FDA-approved drugs that can promote functional recovery in spinal cord injury (SCI). The $411,136 award to the Texas A&M University System Health Science Center will fund a 3-step screening platform using adult cortical...

Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $470,293 to The Research Foundation For The State University of New York (SUNY at Binghamton) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 1, 2025, through June 30, 2027. This Project Grant funds research aimed at identifying and characterizing the electrophysiological features of spinal motor neurons during...

The National Science Foundation Division of Industrial Innovation awarded Spinex Inc. a $255,568 Project Grant under the Engineering (47.041) federal grant program. The grant funded the development of a transcutaneous electrical spinal cord neuromodulator for home use from September 1, 2021 to February 28, 2022. As part of its mission to foster innovation and excellence in engineering, the Engineering program supported Spinex Inc.'s work to advance technologies for non-invasive spinal cord...

Federal Project Grant Award Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded Shirley Ryan AbilityLab a $2.86 million project grant effective September 1, 2025, through August 31, 2028, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds research investigating paired stimulation plasticity methods to enhance motor recovery in individuals with cervical spinal cord injury (SCI). The...

This Project Grant award of $305,447, issued on September 2, 2024 by the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research), aims to identify predictive biomarkers for acute intermittent hypoxia-induced motor recovery in individuals with incomplete spinal cord injury. The research team from the University of Colorado will: 1) Validate the cellular mechanisms underlying hypoxia-induced plasticity in humans, using...

This $425,167 National Science Foundation (NSF) Engineering (CFDA 47.041) award to The Research Foundation for the State University of New York supports the development of a novel multifunctional soft neural probe technology. The goal is to use this new device to study the pathophysiology of spinal cord injuries and explore approaches to promote functional recovery. The award will fund the creation of soft polymer-based probes capable of optical stimulation, electrical recording, drug...

This National Science Foundation Project Grant award of $468,072 supports research at The Trustees of the Stevens Institute of Technology to develop personalized virtual reality interfaces for motor rehabilitation. The goal is to optimize outcomes for individuals with spinal cord or brain injuries undergoing physical therapy. The researchers will examine how impairment levels affect performance, physiological responses, and perceptions during VR training that adapts task difficulty and augmented...

The National Institute of Neurological Disorders and Stroke (NINDS), through the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), awarded Versapeutics Inc. a $2,380,552 federal project grant on September 18, 2023 to conduct toxicology and efficacy studies of their novel antibody therapeutic Versamab-101 for treating spinal cord injury. Versapeutics, a for-profit biotechnology company, will utilize the funding to evaluate the safety profile and determine...